GENCO Acquires Capital Returns

GENCO announced it has acquired Capital Returns, a industry leader in pharmaceutical returns management and disposition, headquartered in Milwaukee, Wis. Capital Returns will operate as a separate GENCO business unit under its existing name and current president and CEO, Robert Ryan. Republic Partners represented and advised GENCO on the transaction. Terms of the acquisition were not disclosed.

Founded in 1991, Capital Returns has been a driving force of innovation, resulting in the development of many pharmaceutical industry firsts, says GENCO. Included are a proprietary Web-based system, CapNet, which gives customers constant access to critical returns data; services across all classes of trade; HIPAA compliance solutions; a Windows-based return-to-stock system for minimizing future outdates and a returns cycle average time of less than one week.

Herb Shear, president and CEO of GENCO said, “Capital Returns fits perfectly with our growth strategy by expanding our reverse logistics capabilities and offers us an immediate leadership position in the pharmaceutical returns market.”

Robert Ryan, president and CEO of Capital Returns, said, "GENCO brings a strategic, long-term commitment to Capital Returns, which will enable us to make additional investments to build on our successes. The alignment of the two companies is remarkable and unprecedented, and we are thrilled to join the GENCO team."